Course InformationTherapautic Area: Rheumatology
Activity Dates: September 11, 2013 - September 10, 2014
This course is still available as a learning tool but has expired for CME credit.
The challenge of providing uniformly effective rheumatoid arthritis care has thus far defied a simple solution. Variations in care range from the appropriate adjustment or switching of therapy subsequent to increased disease activity to the selection of therapeutic agent chosen following failure. This program is designed to improve the understanding of advances in immunopathologic discoveries which provide valuable aid in individualized treatment plans and the appropriate patient selection of available DMARDS and biologic therapeutics. Also, expert rheumatologists will discuss the latest data of head-to-head trials and recommendations for clinical effectiveness. This CME program will bring rheumatologists and other health care professionals up to date in managing their patients with rheumatoid arthritis.
This activity was designed to meet the needs of rheumatologists, immunologists, primary care practitioners and other healthcare professionals who care for patients with rheumatoid arthritis.
- Explain the advances in immunopathologic discoveries in rheumatoid arthritis and how this is shaping the development of therapies
- Compare the benefits, risks, and modes of action of available DMARD and biologic therapeutics
- Analyze the latest data of head-to-head trials that provide information on clinical effectiveness
- Develop individualized management strategies for rheumatoid arthritis that utilizes guideline recommendations for diagnosis, treatment adjustments, and sequencing of agents complemented by clinical experience